TPG (NASDAQ:TPG) is a global alternative asset firm that focuses on private equity, real estate, and public market investments. On October 21, 2025, Morgan Stanley set a price target of $63 for TPG, suggesting a potential price increase of approximately 11.47% from its current stock price of $56.52. This indicates confidence in TPG's growth prospects.
Recently, TPG, in collaboration with Blackstone, announced a significant acquisition of Hologic, a women's health company, for up to $18.3 billion. This strategic move into the healthcare sector highlights TPG's intent to diversify and strengthen its investment portfolio. The acquisition involves purchasing all outstanding shares of Hologic at $76 each in cash.
TPG's stock price currently stands at $56.58, reflecting a 1.35% increase or $0.76. The stock has traded between $55.55 and $56.74 today. Over the past year, TPG's stock has seen a high of $72.98 and a low of $37.52, indicating some volatility in its market performance.
With a market capitalization of approximately $21.03 billion, TPG is a significant player in the financial sector. The company's recent acquisition of Hologic is expected to enhance its market position and potentially drive future growth. Today's trading volume for TPG is 343,613 shares, reflecting active investor interest.
The collaboration with Blackstone in acquiring Hologic marks a major move in the medical device sector. This acquisition aligns with TPG's strategic interest in expanding its presence within the healthcare industry, potentially contributing to the anticipated stock price increase suggested by Morgan Stanley.
